Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Ring stacking in solutions of norepinephrine and the 4:1 norepinephrine . ATP complex.

Moon BH, Pai VS, Maynert EW.

Mol Pharmacol. 1981 Jan;19(1):44-8. No abstract available.

PMID:
7207462
2.

Phenobarbital: chemical-biophysical effects.

Maynert EW, Kusek JC.

Adv Neurol. 1980;27:541-52. Review. No abstract available.

PMID:
6155060
3.

Effects of intraventricularly administered monoamines on seizure susceptibility and body temperature in rats.

Browning RA, Maynert EW.

Neuropharmacology. 1978 Aug;17(8):649-53. No abstract available.

PMID:
692824
4.

Effect of intracisternal 6-hydroxydopamine on seizure susceptibility in rats.

Browning RA, Maynert EW.

Eur J Pharmacol. 1978 Jul 15;50(2):97-101.

PMID:
679982
5.

Alterations in morphine analgesia produced by chronic deficits of brain catecholamines or serotonin: role of analgesimetric procedure.

York JL, Maynert EW.

Psychopharmacology (Berl). 1978 Mar 1;56(2):119-25. No abstract available.

PMID:
417362
6.

Modes of action of toxic agents.

Maynert EW, Hammond BG.

Ann Clin Lab Sci. 1976 Jul-Aug;6(4):322-31.

PMID:
962296
7.

The role of the neurotransmitters in the epilepsies.

Maynert EW, Marczynski TJ, Browning RA.

Adv Neurol. 1975;13:79-147. Review. No abstract available.

PMID:
3107
8.

Insoluble solid complexes of norepinephrine and adenosine triphosphate.

Maynert EW, Moon BH, Pai VS.

Mol Pharmacol. 1972 Jan;8(1):88-94. No abstract available.

PMID:
5061520
9.

Interactions of catecholamines with adenosine triphosphate in solutions and adrenal medullary granules.

Pai VS, Maynert EW.

Mol Pharmacol. 1972 Jan;8(1):82-7. No abstract available.

PMID:
4334445
10.

Epoxides as obligatory intermediates in the metabolism of olefins to glycols.

Maynert EW, Foreman RL, Watabe T.

J Biol Chem. 1970 Oct 25;245(20):5234-8. No abstract available.

11.

The role of biochemical and neurohumoral factors in the laboratory evaluation of antiepileptic drugs.

Maynert EW.

Epilepsia. 1969 Jun;10(2):145-62. Review. No abstract available.

PMID:
4308258
12.

A racemic form of 5-ethyl-5-(3-hydroxy-1-methylbutyl)barbituric acid as a metabolite of pentobarbital.

Maynert EW.

J Med Chem. 1969 Jan;12(1):180-1. No abstract available.

PMID:
5763022
13.

VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.

Maynert EW.

Res Publ Assoc Res Nerv Ment Dis. 1968;46:89-95. No abstract available.

PMID:
5749391
14.

Uptake and binding of serotonin by the platelet and its granules.

Maynert EW, Isaac L.

Adv Pharmacol. 1968;6(Pt A):113-22. No abstract available.

PMID:
5664039
15.

The effects of repeated flurothyl-induced seizures on convulsive thresholds and brain monoamines in rats.

Adler MW, Sagel S, Kitagawa S, Segawa T, Maynert EW.

Arch Int Pharmacodyn Ther. 1967 Nov;170(1):12-21. No abstract available.

PMID:
4383498
16.

Some aspects of the comparative pharmacology of morphine.

Maynert EW.

Fed Proc. 1967 Jul-Aug;26(4):1111-4. No abstract available.

PMID:
4381930
17.

On the specificity of penultimate oxidation. The fate of 5-ethyl-5-n-hexylbarbituric acid.

Maynert EW.

J Pharmacol Exp Ther. 1965 Dec;150(3):476-83. No abstract available.

PMID:
5854854
18.

The alcoholic metabolites of pentobarbital and amobarbital in man.

Maynert EW.

J Pharmacol Exp Ther. 1965 Oct;150(1):118-21. No abstract available.

PMID:
5855308
19.

NOREPINEPHRINE AND 5-HYDROXYTRYPTAMINE IN RAT BRAIN STEM FOLLOWING CORTICAL LESIONS.

ADLER MW, KURIYAMA K, MAYNERT EW.

Life Sci (1962). 1965 Jan;4:141-4. No abstract available.

PMID:
14283075
20.

SOME OBSERVATIONS ON NERVE-ENDING PARTICLES AND SYNAPTIC VESICLES.

MAYNERT EW, KURIYAMA K.

Life Sci (1962). 1964 Sep;3:1067-87. Review. No abstract available.

PMID:
14206044
21.

THE SUBCELLULAR LOCALIZATION OF BRAIN-STEM NOREPINEPHRINE AND 5-HYDROXYTRYPTAMINE IN STRESSED RATS.

LEVI R, MAYNERT EW.

Biochem Pharmacol. 1964 Apr;13:615-21. No abstract available.

PMID:
14191868
22.

THE RELEASE OF 5-HYDROXYTRYPTAMINE, POTASSIUM AND AMINO ACIDS FROM PLATELETS.

BUCKINGHAM S, MAYNERT EW.

J Pharmacol Exp Ther. 1964 Mar;143:332-9. No abstract available.

PMID:
14161145
23.

STRESS-INDUCED RELEASE OF BRAIN NOREPINEPHRINE AND ITS INHIBITION BY DRUGS.

MAYNERT EW, LEVI R.

J Pharmacol Exp Ther. 1964 Jan;143:90-5. No abstract available.

PMID:
14118083
24.

The action of thromb in on platelet 5-hydroxytryptamine.

GAINTNER JR, JACKSON DP, MAYNERT EW.

Bull Johns Hopkins Hosp. 1962 Oct;111:185-97. No abstract available.

PMID:
13946147
25.

On the relationship of brain gamma-aminobutyric acid to convulsions.

MAYNERT EW, KAJI HK.

J Pharmacol Exp Ther. 1962 Jul;137:114-21. No abstract available.

PMID:
14471743
26.

Tolerance to morphine. I. Effects on catecholamines in the brain and adrenal glands.

MAYNERT EW, KLINGMAN GI.

J Pharmacol Exp Ther. 1962 Mar;135:285-95. No abstract available.

PMID:
14471745
27.

Tolerance to morphine. II. Lack of effects on brain 5-hydroxytryptamine and gamma-aminobutyric acid.

MAYNERT EW, KLINGMAN GI, KAJI HK.

J Pharmacol Exp Ther. 1962 Mar;135:296-9. No abstract available.

PMID:
14471744
28.

Tolerance to morphine. III. Effects on catecholamines in the heart, intestine and spleen.

KLINGMAN GI, MAYNERT EW.

J Pharmacol Exp Ther. 1962 Mar;135:300-5. No abstract available.

PMID:
14457033
29.

The metabolic fate of diphenylhydantoin in the dog, rat and man.

MAYNERT EW.

J Pharmacol Exp Ther. 1960 Nov;130:275-84. No abstract available.

PMID:
13768600
30.

The metabolism of butabarbital (butisol) in the dog.

MAYNERT EW, LOSIN L.

J Pharmacol Exp Ther. 1955 Nov;115(3):275-82. No abstract available.

PMID:
13272177
31.

The distribution and fate of dialkylbarbiturates.

MAYNERT EW.

Fed Proc. 1952 Jun;11(2):625-31. No abstract available.

PMID:
14945526
32.

Ethyl(3-hydroxy-n-butyl)barbituric acid as a metabolite of neonal.

MAYNERT EW.

J Biol Chem. 1952 Mar;195(1):403-6. No abstract available.

33.

Ethyl (3-hydroxyisoamyl) barbituric acid as the principal metabolite of amytal.

MAYNERT EW.

J Biol Chem. 1952 Mar;195(1):397-402. No abstract available.

34.

Ethyl (3-hydroxy-1-methylbutyl) barbituric acids as metabolites of pentobarbital.

MAYNERT EW, DAWSON JM.

J Biol Chem. 1952 Mar;195(1):389-95. No abstract available.

35.

[Quantitative determination of diethylbarbituric acid in blood and urine].

GIOTTI A, MAYNERT EW.

Boll Soc Ital Biol Sper. 1951 Mar;27(3 bis):347-9. Undetermined Language. No abstract available.

PMID:
14858663
36.

The renal clearance of barbital and the mechanism of its reabsorption.

GIOTTI A, MAYNERT EW.

J Pharmacol Exp Ther. 1951 Mar;101(3):296-309. No abstract available.

PMID:
14825086
37.

The absence of localization of barbital in divisions of the central nervous system.

MAYNERT EW, VAN DYKE HB.

J Pharmacol Exp Ther. 1950 Feb;98(2):184-7. No abstract available.

PMID:
15422513
38.

The metabolism of amytal labeled with N15 in dogs.

MAYNERT EW, VAN DYKE HB.

J Pharmacol Exp Ther. 1950 Feb;98(2):180-3. No abstract available.

PMID:
15422512
39.

The metabolic fate of pentobarbital; isotope dilution experiments with urine after the administration of labeled pentobarbital.

MAYNERT EW, VAN DYKE HB.

J Pharmacol Exp Ther. 1950 Feb;98(2):174-9. No abstract available.

PMID:
15422511
40.

The isolation of a metabolite of pentobarbital.

MAYNERT EW, VAN DYKE HB.

Science. 1949 Dec 16;110(2868):661. No abstract available.

PMID:
15407675
41.

The metabolism of barbiturates.

MAYNERT EW, VAN DYKE HB.

Pharmacol Rev. 1949;1(2):217-42. No abstract available.

PMID:
18137904

Supplemental Content

Loading ...
Support Center